Hyperfibrinolysis and acquired factor XIII deficiency in newly diagnosed pediatric malignancies

• Verena Wiegering,
• Oliver Andres,
• Paul G. Schlegel,
• Frank Deinlein,
• Matthias Eyrich,
• Alexander Sturm

Affiliations

Verena Wiegering

Division of Pediatric Hematology, Hemostaseology, Oncology and Stem Cell Transplantation, University Children’s Hospital Würzburg, Germany

Oliver Andres

Division of Pediatric Hematology, Hemostaseology, Oncology and Stem Cell Transplantation, University Children’s Hospital Würzburg, Germany

Paul G. Schlegel

Division of Pediatric Hematology, Hemostaseology, Oncology and Stem Cell Transplantation, University Children’s Hospital Würzburg, Germany

Frank Deinlein

Division of Pediatric Hematology, Hemostaseology, Oncology and Stem Cell Transplantation, University Children’s Hospital Würzburg, Germany

Matthias Eyrich

Division of Pediatric Hematology, Hemostaseology, Oncology and Stem Cell Transplantation, University Children’s Hospital Würzburg, Germany

Alexander Sturm

Division of Pediatric Hematology, Hemostaseology, Oncology and Stem Cell Transplantation, University Children’s Hospital Würzburg, Germany